#TITLE_ALTERNATIVE#

Diabetic nephropathy is a microvascular complication of diabetes melitus characterized by chronic <br /> <br /> kidney disease (CKD). The main component in the diabetic nephropathy therapy is the use of <br /> <br /> antidiabetic and antihypertension in controlling blood gluc...

Full description

Saved in:
Bibliographic Details
Main Author: NUR ASTIANI NIM : 11614014, MELI
Format: Final Project
Language:Indonesia
Online Access:https://digilib.itb.ac.id/gdl/view/28854
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Institut Teknologi Bandung
Language: Indonesia
Description
Summary:Diabetic nephropathy is a microvascular complication of diabetes melitus characterized by chronic <br /> <br /> kidney disease (CKD). The main component in the diabetic nephropathy therapy is the use of <br /> <br /> antidiabetic and antihypertension in controlling blood glucose levels and blood pressure to slow <br /> <br /> the rate of kidney damage. The purpose of this study was to determine the pattern of treatment <br /> <br /> and drugs usage, as well as evaluate the accuracy of the usage of antidiabetic and antihypertension <br /> <br /> to patients with diabetic nephropathy in one of Bandung Private Hospitals based on based on <br /> <br /> aspects of right indication, right drug, and right dose. This study is a analytic obeservational <br /> <br /> retrospectively study by reviewing data from medical records in the period of January 2016 - <br /> <br /> December 2017. The results showed that the antidiabetic treatment pattern in diabetic <br /> <br /> nephropathy patients was monotherapy glimepirid. The evaluation results for the accuracy of <br /> <br /> antidiabetic usage showed 100% exact indication, 93.93% right medication, and 100% right dose. <br /> <br /> Treatment results during hospitalization showed 66.67% had blood glucose levels when under <br /> <br /> control and 33.33% had blood glucose levels when uncontrolled. While the antihypertension <br /> <br /> treatment pattern in diabetic nephropathy patients was the use of a combination of angiotensin <br /> <br /> receptor blocker (ARB) and calcium channel blocker (CCB), the most widely used antihypertension <br /> <br /> is the CCB group, namely amlodipine. The evaluation results for the accuracy of antihypertension <br /> <br /> usage showed 100% exact indications, 88.89% right medication, and 91.67% right dose. Treatment <br /> <br /> results during hospitalization showed 63.89% had controlled blood pressure and 36.11% had <br /> <br /> uncontrolled blood pressure. <br />